Wuxi Apptec Co.Ltd(603259) : special report on the deposit and actual use of raised funds in 2021

Securities code: Wuxi Apptec Co.Ltd(603259) securities abbreviation: Wuxi Apptec Co.Ltd(603259) Announcement No.: pro 2022022

Wuxi Apptec Co.Ltd(603259)

Special report on the deposit and actual use of raised funds in 2021

The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.

1、 Basic information of raised funds

(I) funds raised from initial public offering of a shares

With the approval of the reply on approving Wuxi Apptec Co.Ltd(603259) initial public offering (zjxk [2018] No. 678) of China Securities Regulatory Commission (hereinafter referred to as “CSRC”), Wuxi Apptec Co.Ltd(603259) (hereinafter referred to as “the company” or ” Wuxi Apptec Co.Ltd(603259) “) publicly issued 104198556 ordinary shares (A shares) in Shanghai Stock Exchange at an issue price of 21.60 yuan per share, The total amount of funds raised from stock issuance is RMB

225068880960 yuan, after deducting the issuance expenses of 12040340960 yuan, the actual net amount of raised funds is 213028540000 yuan. The actual amount received is RMB 216066125722, including other issuance expenses that have not been transferred, which are RMB 3037585722 (among which, other issuance expenses that have been paid from the company’s own capital account in the early stage are RMB 1251841465, and those that have not been paid are RMB

His issuance fee is RMB 1785744257). The aforesaid funds have all arrived on May 2, 2018

The account has been verified by Deloitte Huayong Certified Public Accountants (special general partnership) and a capital verification report of DSB (y) Zi (18) No. 00197 has been issued.

As of December 31, 2021, the company has accumulated 149072241709 yuan of raised funds

Yuan. The balance of unused raised funds is RMB 74896665936, of which RMB 22000000000 is used for cash management to purchase financial products, and RMB 52896665936 is deposited in the regulatory bank (including the net amount of interest income and financial income generated by raised funds after deducting bank renewal fees and others is RMB 10940367645).

As of December 31, 2021, the bank accounts of raised funds related to the funds raised by the initial public offering of a shares

The ending balance of the account is 52896665936 yuan in total. The specific deposit conditions are as follows:

Unit: RMB

Name of deposit bank name of deposit company name of account opening account number funds to May 2, 2018 initial deposit amount to December 31, 2021 deposit balance

Ping An Bank Co.Ltd(000001) shares 15062018041

Shanghai Branch Sales Department of the company 800564000 Ping An Bank Co.Ltd(000001) 65538614

Shares

Shanghai Branch 51090204101200000 Ping An Bank Co.Ltd(000001) 1061086 free trade test division 08022018

Bank business department may

Bank Of Communications Co.Ltd(601328) shares 322 Inner Mongolia Tianshou Technology&Development Co.Ltd(000611) 012

Co., Ltd. Wuxi company 801803089166946145722638397304 helangkou sub branch

Shanghai Pudong Development 98460078801

Bank Co., Ltd. our company 7 Shenzhen Guohua Network Security Technology Co.Ltd(000004) 617271998000043590070433 Baoshan sub branch

Shanghai Pudong development Suzhou Wuxi Apptec Co.Ltd(603259)

Bank Co., Ltd. new drug development Co., Ltd. 98460078801 – 4439764312 Baoshan sub branch company (“Suzhou pharmaceutical 2 Shenzhen Guohua Network Security Technology Co.Ltd(000004) 93″)

(Ming)

Ping An Bank Co.Ltd(000001) shares Tianjin Wuxi Apptec Co.Ltd(603259)

Tianjin new drug development Co., Ltd. 150 Beijing Centergate Technologies (Holding) Co.Ltd(000931) 77 not applicable – 4051571260 Binhai sub branch company (“Tianjin Pharmaceutical 419”)

(Ming)

China Merchants Bank Co.Ltd(600036) shares Shanghai Wuxi Apptec Co.Ltd(603259)

Shanghai New Drug Development Co., Ltd. 51090204731 – 262927 free trade test division (“Shanghai Pharmaceutical 0103”)

Bank business department

Total 21606612572252896665936

Note: the ending balance includes the accumulated interest income and wealth management income received, and the net amount after deducting bank charges and others is RMB 10940367645.

(II) funds raised from non-public offering of A-Shares in 2020

With the approval of the reply on the approval of Wuxi Apptec Co.Ltd(603259) non-public Development Bank shares (zjxk [2020] No. 1828 document) issued by the CSRC, the company is approved to issue no more than 105000000 new shares in non-public, with a par value of RMB 1.00 per share.

The company will issue 62690290 ordinary shares in RMB in this non-public offering at an issue price of 104.13 yuan per share. The total amount of funds raised from stock issuance is 652793989770 yuan. After deducting the issuance expenses of RMB 6669361226 (excluding tax), the net amount of actually raised funds is RMB 646124628544. After deducting the deductible VAT input tax of RMB 400161674 from the issuance expenses of this non-public offering and adding back the other issuance expenses that have not been transferred, the actual amount received is calculated

646592446870 yuan. The above actually raised funds of RMB 646592446870 have been in 2020

All accounts were received on September 8, which was verified by Deloitte Huayong Certified Public Accountants (special general partnership) and issued the capital verification report DSB (y) Zi (20) No. 00517.

As of December 31, 2021, the company has accumulated 519262118166 yuan of raised funds. The balance of the unused raised funds is 136213395195 yuan (including the interest income and wealth management income generated by the raised funds, and the net amount after deducting bank charges and others is 9350884817 yuan).

As of December 31, 2021, the closing balance of the bank account of the raised funds related to the non-public offering of A-Shares of the company in 2020 amounted to RMB 136213395195. The specific deposit conditions are as follows: unit: RMB

Name of deposit bank account opening company account opening account funds to September 8, 2020 initial deposit amount to December 31, 2021 deposit balance

Bank Of Communications Co.Ltd(601328) share ownership

Wuxi Helong branch of the company 322 Inner Mongolia Tianshou Technology&Development Co.Ltd(000611) 01736280 Ping An Bank Co.Ltd(000001) 1264789489 Shanghai Kaibao Pharmaceutical Co.Ltd(300039) 4273

Shanghai Pudong Development Bank

Bank Co., Ltd. our company 98460078801491760 Shenzhen Fountain Corporation(000005) 502469823 Baoshan sub branch 900 Ningxia Qinglong Pipes Industry Group Co.Ltd(002457)

Bank Of Communications Co.Ltd(601328) share ownership

Wuxi Helong branch of the company 322 Inner Mongolia Tianshou Technology&Development Co.Ltd(000611) 01660640 Shenzhen Quanxinhao Co.Ltd(000007) 15350260 Shanghai Kaibao Pharmaceutical Co.Ltd(300039) 5171

Bank Of Communications Co.Ltd(601328) shares in 2020

Wuxi Helong branch of the Company Limited 322 Inner Mongolia Tianshou Technology&Development Co.Ltd(000611) 01 September 81789260 Shenzhen Guohua Network Security Technology Co.Ltd(000004) 5662172105 mouth sub branch Shanghai Kaibao Pharmaceutical Co.Ltd(300039) 5247

Shanghai Pudong Development Bank

Bank Co., Ltd. our company 98460078801300 Ping An Bank Co.Ltd(000001) 6696289381 Baoshan sub branch 700 Shandong Yisheng Livestock & Poultry Breeding Co.Ltd(002458)

Shanghai Pudong Development Bank

Bank Co., Ltd. the company 98460078801 Shanghai Pudong Development Bank Co.Ltd(600000) 00000

Baoshan sub branch 500 Ja Solar Technology Co.Ltd(002459) 23179732149 Shanghai Pudong Development Bank

Bank Co., Ltd. our company 98460078801188798446870778921326 Baoshan sub branch China Vanke Co.Ltd(000002) 460

Wuxi Hequan

China Merchants Bank Co.Ltd(600036) Co., Ltd

Company (“no 5109 Shandong Wit Dyne Health Co.Ltd(000915) 1 not applicable – 802792570 limited company Wuxi Branch Xihe General Pharmaceutical 0956

Industry “)

Shanghai Hequan

China Agricultural Bank Of China Limited(601288) shares Pharmaceutical Co., Ltd

109608 Shanghai Co., Ltd. 03857600040 – 6230120527 Jinshan sub branch (“Hequan”)

Pharmaceutical industry “)

Changzhou Hequan

China China Minsheng Banking Corp.Ltd(600016) stock Pharmaceutical Co., Ltd

Guangzhou Hequan Pharmaceutical Co., Ltd. Shanghai Branch (chang632402943 – 6112558619 branch)

Industry “)

China Merchants Bank Co.Ltd(600036) shares include Changzhou Hequan 12193694571 – 9391285755 Co., Ltd. Shanghai branch pharmaceutical 0590

Shanghai Hequan

Shanghai Pudong Development Bank pharmaceutical research and Development Co., Ltd

Bank Co., Ltd. 98460078801 – 727491279 Baoshan sub branch (“Hequan pharmaceutical 20 Guangxi Liugong Machinery Co.Ltd(000528)

Materials development “)

China China Construction Bank Corporation(601939) shares

Shanghai Yaoming 31050110057 – 9149421912 pilot Free Trade Zone Branch 9 Shenzhen Overseas Chinese Town Co.Ltd(000069) 37

- Advertisment -